**Excerpt:**
Regenerative stem cell therapy holds immense promise for the treatment of cardiomyopathy, a debilitating heart condition. This article analyzes the latest advances in stem cell-based approaches, exploring their potential to restore myocardial function, reduce fibrosis, and improve patient outcomes.
Mesenchymal stem cell (MSC) therapy holds promise for non-ischemic cardiomyopathy (NICM), a condition with limited treatment options. MSCs have demonstrated regenerative and immunomodulatory properties, offering potential benefits in improving cardiac function and reducing inflammation. Research has explored the mechanisms and clinical applications of MSC therapy for NICM, providing insights into its therapeutic potential.
0 Comments